General Information 541-754-1150
Same-Day Appointments at CareNow

Corvallis Clinic Health Information Blog

“Registry studies” another aid to research

May 04, 10:43 AM

Clinical Research Center

When most people think of clinical research studies, they think of experimental treatments such as investigational oral or injectable medications.  However, not all studies involve a treatment intervention.  Some studies are designed to simply track the health and disease progression of patients who meet study criteria. 

Such studies are called “registry studies,” and the patients in these studies are carefully selected because they have a disease or condition of interest.  Although registry studies do not provide any treatment, these studies are an important way for medical researchers to learn more about medications that are already approved and effects they have on patients in a real-world setting. The information collected from these studies may ultimately lead to advances in treatment.

The Clinical Research Center is currently looking for volunteers to participate in a registry study for those with relapsing forms of multiple sclerosis (MS).  The purpose of the study is to follow registry patients for five years to collect long-term safety information.  Patients in this study will include those with a newly prescribed FDA-approved disease-modifying therapy (a treatment designed to reduce disease activity and progression) for MS. For this study, the FDA approved disease modifying therapies allowed are: Aubagio, Avonex, Betaseron, Copaxone, Extavia, Gilenya, Plegridy, Rebif, and Tecfidera.

In addition, patients who are changing from one disease-modifying therapy to another may also be eligible for enrollment. 

Registry study participants will continue with their regular treatment by their own doctor and will fill their own prescriptions.  It may be possible to combine study visits with regular visits to the patient’s treating physician. All patients will have a study-provided skin exam and will have the option to complete a set of surveys; some patients will also have an eye exam or heart tests such as an ECG (an exam which traces the electrical activity of the heart).  At each study visit, patients will be asked about any changes to their medications or about any changes to their health, MS related or not. 

The MS registry study is the first at the Clinical Research Center with neurologist Dr. Weijia “Alex” Wang at the helm.  Dr. Wang’s expertise as a neurologist and his experience as a neuroscience researcher at Cornell, Mount Sinai and JFK Medical Centers makes him the ideal doctor for this important research. 

For more information about the registry study, or any of our other clinical trials, contact the Clinical Research Center at 541-766-2163 or send an email to  You can also follow us on Facebook at

- Julie Carrico is Associate Coordinator of The Corvallis Clinical Research Center 

Thanks to all who participated in our first video

Apr 07, 11:14 AM

Clinical Research Center

While the film awards season was in full swing in February, Clinical Research Center doctors, nurses and patients were busy taking their star turns in the first in a series of videos created to showcase our work. 

Several Corvallis Clinic physicians who conduct research studies were interviewed by the professional videographer prior to developing the video content.  Their answers on why they have chosen to participate in research and how research  benefits patients reflect the “patient first” attitude of our team of which I’m proud to be a member.

A few of the research nurses were also interviewed prior to filming. The nurses described how enjoyable it is to work one-on-one with each patient.  One nurse stated that in research “we’re treating the future” and this became the touchstone phrase for the entire video project.

I was personally gratified with how easy it was to recruit patients to appear in the videos. Given the positive feedback we regularly receive about our service, I was expecting it wouldn’t be difficult to find volunteers. Having that affirmed was fantastic.  Patients were more than willing to speak about their experiences in research and were so generous to volunteer their time for filming.

Thank you doctors, nurses and patients who appear in the videos, as well as the staff who worked so diligently behind the scenes during the filming process.  You all deserve an Oscar!  The first video to be released can be viewed here.

If you are interested in learning more about our studies contact the Clinical Research Center at 541-766-2163 or send an email to  Or, follow us on Facebook at

 - Julie Carrico is Associate Coordinator of The Corvallis Clinical Research Center. 

Meet Nancy

Jan 21, 10:18 AM

Clinical Research Center

Nancy Sarpola, RN, is the last clinical research coordinator to be introduced to you via this blog.  For the past several months, Nancy has been working quietly in the background supporting all of us in a variety of clinical studies.  Now, it’s Nancy’s turn in the spotlight as she is enrolling not one, but two studies in different therapeutic areas.  Nancy is the coordinator for a new study for those with Type 1 diabetes and another for those with high triglyceride levels (hypertriglyceridemia). 

Nancy is a passionate and generous gardener.  It is a much-anticipated department tradition to hold a staff meeting each summer while basking in the beauty of Nancy’s floral wonderland – words are inadequate to describe her amazing landscape.  Nancy also enjoys spending time with her family and especially her first grandchild, who will no doubt have a “green thumb.”Nancy obtained her undergraduate degree from Oregon State University and then attended nursing school. She began her nursing career in 1988 and all but one year of her career has been at The Corvallis Clinic.  Prior to joining Research, Nancy worked in Obstetrics/Gynecology and the Anticoagulation Clinic.  She joined the Clinical Research Center nine years ago and has been involved in 20 clinical trials, including cardiovascular disease, diabetes, Alzheimer’s disease, women’s health, and COPD.

The Type 1 diabetes study is evaluating an investigational insulin designed to be as similar as possible to Lantus® (insulin glargine) to see how well it works to control blood sugar levels.  Patient volunteers must be between 18 and 65 years old and taking Lantus® (insulin glargine) for at least three months.  The hypertriglyceridemia study is looking at an investigational medication to help reduce the risk of serious heart problems in people who have high triglyceride levels.  The investigational medication is a concentrate of omega-3 free fatty acids, developed from fish oils.

If you are interested in learning more about our studies contact the Clinical Research Center at 541-766-2163 or send an email to  Or, follow us on Facebook at

- Julie Carrico is Associate Coordinator of The Corvallis Clinical Research Center 

Columns by Clinic providers in 2014 helped guide readers to a healthy day - and life

Jan 02, 03:49 PM

We at The Corvallis Clinic strive to deliver exceptional medical care with compassion. We also have a committment to service.  Part of that service is helping guide people to live healthier lives by sharing our providers' expertise. During 2014, many of our physicians, nurse practitioners and physician assistants wrote columns on various subjects, such as men's preventive health, poison oak, pain managment and weight loss.

To start reading columns that will help you have a healthy day, click 2014 columns.

2015: Another busy year ahead

Jan 02, 09:47 AM

Clinical Research Center

One of the great aspects of our jobs as clinical research coordinators is that we are always getting to learn new things.  If a study is in a therapeutic area we are already well versed in, at a minimum we have the opportunity to refresh our knowledge with the very latest clinical information.  The advantage for our clinical trial patients is that we can then pass on this “cutting-edge” knowledge. 

During 2014 we worked in several clinical areas, including allergy, Type 1 and Type 2 diabetes, women’s health, psoriasis, multiple sclerosis, asthma, chronic obstructive pulmonary disease (COPD), a vaccine to prevent C diff infections, and Alzheimer’s disease. 

2015 is shaping up to be an equally busy year for us.  We were selected to participate in a study that will be very interesting for those with high levels of triglycerides (hypertriglyceridemia) even though they are taking a statin drug and watching their diet.  Another exciting study is working with patients who have had a stroke in the recent past and who need additional help recovering their walking skills.  We have new clinical trials starting for those with uncontrolled asthma and those with COPD, and we have also been selected to participate in a clinical trial evaluating instrumentation improvements in the device used for measuring anticoagulation in patients who use blood thinners.  Whew!

Innovation in medical treatment is truly not possible without the participation of study volunteers.  So, to our many volunteers, I say thanks for keeping us busy in 2014 and we look forward to advancing medicines and technology in 2015.  Happy New Year!

Our current list of clinical studies includes studies for those with Type 1 or Type 2 diabetes, Alzheimer’s disease, uncontrolled asthma, plaque-type psoriasis and hypertriglyceridemia.  For more information, contact the Clinical Research Center at 541-766-2163 or send an email to  You can also follow us on Facebook at

- Julie Carrico is Associate Coordinator of The Corvallis Clinic Clinical Research Center